BML-280 (VU0285655-1) is a potent and selective phospholipase D2 (PLD2) inhibitor. BML-280 has the ability to prevent caspase-3 cleavage and reduction in cell viability induced by high glucose. BML-280 can be used for rheumatoid arthritis research[1][2].
Molecular Weight:
429.51
Purity:
99.64
CAS Number:
[1158347-73-9]
Formula:
C25H27N5O2
Target:
Interleukin Related,Phospholipase,TNF Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted